Frontlight ResearchEarly access
CompletedNo phase
Transcranial Direct Current Stimulation (tDCS) in Human Subjects With PTSD Receiving an Exposure-based, Behavioral Therapy
Key facts
- Who runs it
- The University of Texas Health Science Center at San Antonio
- Where
- San Antonio, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 25 people enrolled
- Started
- 9 Jan 2023
- Ended
- 25 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Soterix 1x1 tDCS mini CT
- Sham Soterix 1x1 tDCS Mini CT
- Written Exposure Therapy (WET)
- Record updated
- 29 May 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Individuals between the ages of 18 and 65 years old at time of screening
- PTSD diagnosis as assessed by the Clinician-Administered Posttraumatic Stress Scale (CAPS-5)
- Able to write, read, and speak English
Who cannot take part
- Change in anticonvulsive or benzodiazepine medication regimen in the past month
- History of adverse effects to previous tDCS or other brain stimulation technique
- Concurrent engagement in another brain simulation technique or trauma-related psychotherapy for PTSD
- History of epilepsy or seizures
- History of significant intracranial pathology (e.g., severe traumatic brain injury) or neurological disorder (e.g., Stroke, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's, Dementia, Parkinson's, and/or Huntington's)
- History of skin condition (e.g., eczema, psoriasis) where electrodes will be applied
- Electronic implants in the body that could be susceptible to electrical current (e.g., cardiac pacemaker, cochlear implants, medical pump)
- Current moderate or severe substance use disorder
- Suicidality and/or psychiatric risk requiring immediate intervention or a higher level of care than can be provided by the study treatment
- Metallic objects other than dental appliances/fillings near the site of stimulation
- Current manic episode or psychotic symptoms requiring immediate stabilization or hospitalization (as determined by clinical judgement)
- Currently pregnant or breastfeeding
Where in United States
- The University of Texas Health Science Center at San AntonioSan Antonio, United States
About the trial
What the trial wants to find out
The primary objective of this study is to evaluate the safety, feasibility, and psychological and physiological treatment benefits of transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique, when delivered in combination with Written Exposure Therapy (WET), for posttraumatic stress disorder posttraumatic stress disorder (PTSD).
The 2 groups in the trial
- tDCS plus WETTreatment being tested
Subjects will receive transcranial direct current stimulation (tDCS) plus written exposure therapy (WET)
Treatment: Soterix 1x1 tDCS mini CT and Written Exposure Therapy (WET)
- Sham plus WETSham treatment, for comparison
Subjects will receive sham transcranial direct current stimulation (tDCS) treatment plus written exposure therapy (WET)
Treatment: Sham Soterix 1x1 tDCS Mini CT and Written Exposure Therapy (WET)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety, Feasibility, and Benefits of Transcranial Direct Current Stimulation (tDCS) in Human Subjects With Posttraumatic Stress Disorder (PTSD) Receiving an Exposure-based, Behavioral Therapy
- Record updated
- 29 May 2025